Robert Alan Schueren - Nov 1, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Nov 1, 2021
Transactions value $
-$1,361,950
Form type
4
Date filed
11/3/2021, 07:32 PM
Previous filing
Oct 26, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $78.1K +6K +27.4% $13.01* 27.9K Nov 1, 2021 Direct F1
transaction NTRA Common Stock Sale -$720K -6K -21.51% $120.00 21.9K Nov 1, 2021 Direct F2
transaction NTRA Common Stock Sale -$720K -6K -27.4% $120.00 15.9K Nov 1, 2021 Direct F2, F3
holding NTRA Common Stock 69.3K Nov 1, 2021 Robert A Schueren & Deborah A Schueren Rev Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -6K -9.88% $0.00 54.8K Nov 1, 2021 Common Stock 6K $13.01 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes 1,281 shares previously reported as owned directly which have been transferred to the Robert A Schueren & Deborah A Schueren Rev Trust.
F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The Reporting Person is a trustee of the Robert A Schueren & Deborah A Schueren Rev Trust, and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F5 The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.